肝内胆管癌外科治疗进展
收稿日期: 2022-01-20
网络出版日期: 2022-06-16
基金资助
国家自然科学基金(81772521);上海交通大学医学院附属新华医院院级临床研究培育基金(17CSK06);上海交通大学医学院多中心临床研究(DLY201807)
Advances in surgical treatment of intrahepatic cholangiocarcinoma
刘深洋, 汤朝晖, 全志伟 . 肝内胆管癌外科治疗进展[J]. 外科理论与实践, 2022 , 27(02) : 100 -106 . DOI: 10.16139/j.1007-9610.2022.02.003
| [1] | Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249. |
| [2] | 童焕军, 于小鹏, 汤朝晖. 从病因学角度看肝内胆管癌的异质性[J]. 肝胆胰外科杂志, 2021, 33(11):641-646. |
| [3] | Hwang S, Lee YJ, Song GW, et al. Prognostic impact of tumor growth type on 7th AJCC staging system for intrahepatic cholangiocarcinoma: a single-center experience of 659 cases[J]. J Gastrointest Surg, 2015, 19(7):1291-1304. |
| [4] | Wu L, Tsilimigras DI, Paredes AZ, et al. Trends in the incidence, treatment and outcomes of patients with intrahepatic cholangiocarcinoma in the USA: facility type is associated with margin status, use of lymphadenectomy and overall survival[J]. World J Surg, 2019, 43(7):1777-1787. |
| [5] | Valle JW, Kelley RK, Nervi B, et al. Biliary tract cancer[J]. Lancet, 2021, 397(10272):428-444. |
| [6] | Moris D, Tsilimigras DI, Kostakis LD, et al. Anatomic versus non-anatomic resection for hepatocellular carcinoma: a systematic review and meta-analysis[J]. EJSO, 2018, 44(7):927-938. |
| [7] | Moris D, Ronnekleiv-Kelly S, Rahnemai-Azar AA, et al. Parenchymal-sparing versus anatomic liver resection for colorectal liver metastases: a systematic review[J]. J Gastrointest Surg, 2017, 21(6):1076-1085. |
| [8] | Si A, Li J, Yang Z, et al. Impact of anatomical versus non-anatomical liver resection on short- and long-term outcomes for patients with intrahepatic cholangiocarcinoma[J]. Ann Surg Oncol, 2019, 26(6):1841-1850. |
| [9] | Zhang XF, Bagante F, Chakedis J, et al. Perioperative and long-term outcome for intrahepatic cholangiocarcinoma: impact of major versus minor hepatectomy[J]. J Gastrointest Surg, 2017, 21(11):1841-1850. |
| [10] | Li MX, Bi XY, Li ZY, et al. Impaction of surgical margin status on the survival outcome after surgical resection of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis[J]. J Surg Res, 2016, 203(1):163-173. |
| [11] | Zhu H, Wang L, Wang M, et al. Prognostic value of resection margin length after surgical resection for intrahepatic cholangiocarcinoma[J]. Am J Surg, 2021, 222(2):383-389. |
| [12] | Murakami S, Ajiki T, Okazaki T, et al. Factors affecting survival after resection of intrahepatic cholangiocarcinoma[J]. Surg Today, 2014, 44(10):1847-1854. |
| [13] | van Vugt JLA, Gaspersz MP, Coelen RJS, et al. The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinoma[J]. HPB(Oxford), 2018, 20(1):83-92. |
| [14] | Reames B, Pawlik TM, Ejaz A, et al. Impact of major vascular resection on short- and long-term outcomes in patients with intrahepatic cholangiocarcinoma[J]. J Clin Oncol, 2017, 35(4_suppl):275. |
| [15] | Reames BN, Ejaz A, Koerkamp BG, et al. Impact of major vascular resection on outcomes and survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis[J]. J Surg Oncol, 2017, 116(2):133-139. |
| [16] | Navarro JG, Lee JH, Kang I, et al. Prognostic significance of and risk prediction model for lymph node metastasis in resectable intrahepatic cholangiocarcinoma: do all require lymph node dissection?[J]. HPB(Oxford), 2020, 22(10):1411-1419. |
| [17] | Chang ME, Lei HJ, Chen MH, et al. Evaluation of prognostic factors and implication of lymph node dissection in intrahepatic cholangiocarcinoma: 10-year experience at a tertiary referral center[J]. J Chin Med Assoc, 2017, 80(3):140-146. |
| [18] | Kim DH, Choi DW, Choi SH, et al. Is there a role for systematic hepatic pedicle lymphadenectomy in intrahe-patic cholangiocarcinoma? a review of 17 years of expe-rience in a tertiary institution[J]. Surgery, 2015, 157(4):666-675. |
| [19] | Zhou R, Lu D, Li W, et al. Is lymph node dissection ne-cessary for resectable intrahepatic cholangiocarcinoma? a systematic review and meta-analysis[J]. HPB(Oxford), 2019, 21(7):784-792. |
| [20] | Yoh T, Cauchy F, Le Roy B, et al. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: a multicenter study[J]. Surgery, 2019, 166(6):975-982. |
| [21] | Kim SH, Han DH, Choi GH, et al. Oncologic impact of lymph node dissection for intrahepatic cholangiocarcinoma: a propensity score-matched study[J]. J Gastrointest Surg, 2019, 23(3):538-544. |
| [22] | Tamandl D, Kaczirek K, Gruenberger B, et al. Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma[J]. Br J Surg, 2009, 96(8):919-925. |
| [23] | Sweigert PJ, Eguia E, Janjua H, et al. Does resection improve overall survival for intrahepatic cholangiocarcinoma with nodal metastases?[J]. Surg Open Science, 2020, 2(3):107-112. |
| [24] | Guglielmi A, Ruzzenente A, Campagnaro T, et al. Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma[J]. J Gastrointest Surg, 2013, 17(11):1917-1928. |
| [25] | Benson AB 3rd, D'Angelica MI, Abbott DE, et al. NCCN guidelines insights: hepatobiliary cancers, version 1.2017[J]. J Natl Compr Canc Netw, 2017, 15(5):563-573. |
| [26] | Okami J, Dono K, Sakon M, et al. Patterns of regional lymph node involvement in intrahepatic cholanglocarcinoma of the left lobe[J]. J Gastrointeat Surg, 2003, 7(7):850-856. |
| [27] | Barth MJ. NCCN clinical practice guidelines in oncology (NCCN Guidelines)[J]. J Natl Compr Canc Netw, 2020, 18(11):1105. |
| [28] | Zhang XF, Xue F, Dong DH, et al. Number and station of lymph node metastasis after curative-intent resection of intrahepatic cholangiocarcinoma impact prognosis[J]. Ann Surg, 2021, 274(6):E1187-E1195. |
| [29] | Xiong Y, Jingdong L, Zhaohui T, et al. A consensus meeting on expert recommendations on operating specifications for laparoscopic radical resection of hilar cholangiocarcinoma[J]. Front Surg, 2021, 8:731448. |
| [30] | Weber SM, Jarnagin WR, Klimstra D, et al. Intrahepatic cholangiocarcinoma: Resectability, recurrence pattern, and outcomes[J]. J Am Coll Surg, 2001, 193(4):384-391. |
| [31] | Franken LC, Coelen RJS, Roos E, et al. Staging Laparoscopy in patients with intrahepatic cholangiocarcinoma: is it still useful?[J]. Visceral Medicine, 2020, 36(6):501-505. |
| [32] | Swaid F, Sucandy I, Tohme S, et al. Changes in performance of more than 1000 minimally invasive liver resections[J]. JAMA Surg, 2020, 155(10):986-988. |
| [33] | Ciria R, Cherqui D, Geller DA, et al. Comparative short-term benefits of laparoscopic liver resection: 9000 cases and climbing[J]. Ann Surg, 2016, 263(4):761-777. |
| [34] | Wu J, Han J, Zhang Y, et al. Safety and feasibility of laparoscopic versus open liver resection with associated lymphadenectomy for intrahepatic cholangiocarcinoma[J]. Biosci Trends, 2020, 14(5):376-383. |
| [35] | Haber PK, Wabitsch S, Kaestner A, et al. Laparoscopic liver resection for intrahepatic cholangiocarcinoma: a single-center experience[J]. J Laparoendosc Adv Surg Tech A, 2020, 30(12):1354-1359. |
| [36] | Shiraiwa DK, Carvalho PFDC, Maeda CT, et al. The role of minimally invasive hepatectomy for hilar and intrahe-patic cholangiocarcinoma: a systematic review of the lite-rature[J]. J Surg Oncol, 2020, 121(5):863-872. |
| [37] | Wei F, Wang G, Din J, et al. Is it time to consider laparoscopic hepatectomy for intrahepatic cholangiocarcinoma? a meta-analysis[J]. J Gastrointest Surg, 2020, 24(10):2244-2250. |
| [38] | Ziogas IA, Giannis D, Esagian SM, et al. Laparoscopic versus robotic major hepatectomy: a systematic review and meta-analysis[J]. Surg Endosc, 2021, 35(2):524-535. |
| [39] | Qiu J, Chen S, Du C. A systematic review of robotic-assisted liver resection and meta-analysis of robotic versus laparoscopic hepatectomy for hepatic neoplasms[J]. Surg Endosc, 2016, 30(3):862-875. |
| [40] | Di Benedetto F, Magistri P. First case of full robotic ALPPS for intrahepatic cholangiocarcinoma[J]. Ann Surg Oncol, 2021, 28(2):865. |
| [41] | Hong K, Georgiades C. Radiofrequency ablation: mechanism of action and devices[J]. J Vasc Interv Radiol, 2010, 21(8):S179-S186. |
| [42] | Andreano A, Brace CL. A comparison of direct heating during radiofrequency and microwave ablation in ex vivo liver[J]. Cardiovasc Intervent Radiol, 2013, 36(2):505-511. |
| [43] | Rubinsky B, Lee CY, Bastacky J, et al. The process of freezing and the mechanism of damage during hepatic cryosurgery[J]. Cryobiology, 1990, 27(1):85-97. |
| [44] | Savic LJ, Chapiro J, Hamm B, et al. Irreversible electroporation in interventional oncology: where we stand and where we go[J]. Rofo, 2016, 188(8):735-745. |
| [45] | Kim GH, Kim PH, Kim JH, et al. Thermal ablation in the treatment of intrahepatic cholangiocarcinoma: a systema-tic review and meta-analysis[J]. Eur Radiol, 2021, 32(2):1205-1215. |
| [46] | Chu HH, Kim JH, Shin YM, et al. Percutaneous radiofrequency ablation for recurrent intrahepatic cholangiocarcinoma after curative resection: multivariable analysis of factors predicting survival outcomes[J]. Am J Roentgenol, 2021, 217(2):426-432. |
| [47] | Sapisochin G, Rodriguez de Lope C, Gastaca M, et al. Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation[J]. Ann Surg, 2014, 259(5):944-952. |
| [48] | Sapisochin G, Rodríguez de Lope C, Gastaca M, et al. “Very early” intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?[J]. Am J Transplant, 2014, 14(3):660-667. |
/
| 〈 |
|
〉 |
